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Abstract
Three inoperable patients with primary hepatoma could be placed on gluconeogenic diets
(minimum carbohydrate-high fat diets) for one to three months. A transient inhibition or a marked
retardation of the tumor growth was observed with these patients and their entire clinical courses
were fairly good. These results confirmed our previous observation with a metastatic liver tumor
patient.
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In our previous study (l) attempted to extend the gluconeogenic dietary
therapy of the Novikoff hepatoma (2) to humans, a transient but definite
growth.inhibiting effect of a low carbohydrate-high fat diet was observed
on a patient with hepatic metastases of malignant melanoma. Since the
original observation was made with the hepatoma transplanted into the
liver, the most pertinent subjects to be studied with the gluconeogenic diet
would be primary hepatoma patients.
The present paper reports three cases of primary hepatoma placed on
gluconeogenic diets for one to three months and then returned to balanced
diets. The tumor growth was inhibited transiently or slowed considerably
during the period of the low carbohydrate regimens.
METERIALS AND METHODS
The principle and practical techniques of placing hepatoma patients on gluco-
neogenic diets were essentially the same as those reported previow3ly (1). Four
inoperable primary hepatoma and one cystic liver patients admitted to the clinic
of the University Department were the subjects of the present study. Except one
primary hepatoma, these patients had cirrhosis of the liver. One of the hepatoma
patients with cirrhosis of the liver could not tolerate the gluconeogenic diet and
served as a control. The cystic liver patient was treated with the gluconeogenic
diet as primary hepatoma before the diagnosis was established and was also in-
cluded as another control to see the effect of the diet on cirrhotic patients.
Metabolite concentrations and enzyme activities in the blood or serum were
determined as described in the previous paper (1) or according to the routine
laboratory methods. Activities of liver and tumor hexokinase (3), glucose 6-phos-
phate dehydrogenase (1), and fructose 1,6-diphosphatase (4) were also measured
at 37°e in some of the patients on necropsied materials.
The days after starting the record of daily dietary intakes were referred to as
the days of dietary treatment throughout the present paper.
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OBSERVATIONS
Case 1. ]. H., a 64.year-old male complaining of a fullness and pains
in the right upper abdomen, was admitted and diagnosed by liver scinti.
scanning and peritoneoscopy as primary hepatoma without cirrhosis of the
liver. He noticed a swelling of the right upper abdomen about one month
before admission. His appetite was normal but he was slightly emaciated;
body weight 59 kg and height 170 em. On admission he had no anemia,
jaundice, and ascites. The abdomen was slightly distended and two groups
of liver tumor mass were palpable; one below the right costal margin and
the other below the xiphoid process (Fig. 1). Peritoneoscopically, most of
the right liver lobe was occupied by the tumor mass and intrahepatic
metastases in the right lobe were present. The rectal examination was
negative.
t
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150 Days
Fig. 1 Schematic representation of palpable hepatic tumors in Case 1.
border of the liver surface. Arrows indicate the days of measurement.
The upper
Dietary intakes of this patient during the entire period of illness are
presented in Fig. 2. The carbohydrate content could be reduced to 10 g
per day for nearly three months without affecting the total caloric intake.
A 3 kg loss of body weight in two weeks and no further loss in another
one month were observed after starting the gluconeogenic dietary regimen.
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Fig. 2 Dietary intakes in Case 1. 0, Oral administration; _, parenteral administ
ration. In this case the oral administration of medium-chain triglycerides was recorded as
parenteral (from 95th to Il0th day). The parenteral administrations of carbohydrate and
fat refer to glucose and Intralipid, respectively, unless otherwise indicated. The small
squares at the bottom indicate a combined antimetabolite therapy (5-fluorouracil, 500 mg;
Mitomycin, 2 mg; Endoxan, 200 mg; and Toyomycin, 1 mg).
The change in body weight thereafter was complicated by the accumula·
tion of ascites. The ascites obtained on 86th day was chylous. TtIe in·
creased triglyceride content in the ascites was lowered considerably by
reducing the dietary fat and by instituting oral administration of medium.
chain triglycerides and intravenous infusion of a fat emulsion, Intralipid
(Apoteksvarucentralen Vitrum, Sweden). Because of a loss of appetite
and a limitation in parenteral administration of fat, the carbohydrate
centent of diet was gradually increased. Around 150th day the patient
became slightly icteric and markedly emaciated, and he died from gastro.
intestinal bleedings.
The change in hepatic tumor size is illustrated in -Fig. 1. The tumor
became slightly smaller and sharply defined following the reduction of
carbohydrate content (days 50 to 70 of dietary therapy). Since an increase
of the tumor in the epigastric region was noted around the 80th day of
the treatment, an antimetabolite therapy was combined (see Fig. 2). The
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tumor growth was not so marked during the period of the antimetabolite
treatment, but he developed anorexia and general weakness. After dis.
continuing the chemotherapy and increasing the carbohydrate content in
the diet, the tumor growth became marked and a metastatic tumor mass
in the left lobe of the liver was palpable.
Liver scintigrams taken on 52nd and 136th days are shown in Fig. 3.
Fig. 3 Liver scintigrams in Case 1. The left, 52nd day and the right, 136th day.
The findings of a liver scintiscanning performed on 20th day, which is
not presented in the figure, were essentially identical to those revealed on
52nd day, indicating no appreciable growth of the tumor during the
initial half. period of the low carbohydrate regimen. The comparison of
the two scintigrams in Fig. 3 confirmed the marked growth of the tumor
observed during the latter half-period of the low carbohydrate dietary
therapy.
The alterations in blood metabolite concentrations during the entire
course of the therapy are shown in Fig. 4. At the time of admission the
metabolite levels were all within the normal limit. No marked increases
in blood citrate concentration were observed even with minimum carbo·
hydrate diets until the patient became emaciated considerably, when a
slow but gradual increase in tumor size was noted. At this time the fasting
blood sugar level tended to fall below the normal lower limit and the
postprandial levels were less than 90 mgjlOOml. These abnormalities of
the blood metabolites were corrected by increasing the dietary carbo-
hydrate content. Although the NEFA concentration was slightly raised by
the low carbohydrate diet, the acetone body reaction in the urine was
negative in most occasions. The triglyceride concentration varied widely
4
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Blood sugars (mg/lOO ml)X10-2, 0; Blood citrate (mM) X4, e; Serum NEFA
(mEg/OX 1, ...... ; Serum triglyceride (mg/lOO ml)X 10-2, .t:::..
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o 50 100 150 Days
Fig. 4 Metabolite concentrations in the fasting blood and serum in Case 1. NEFA,
Non-esterified fatty acids.
within the normal range. Fecal lipid contents were not abnormally In-
creased.
GOT (K. U.)X 10-2, ...... ; GPT (K. D.) X 10-2, .t:::..; ICDH (mD/hr/ml)X5X 10-4,
Alkaline phosphatase (B. D.)X 10-1, 0; LAP(G-R D.)X2X 10-3, e
X·,
2
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Fig. 5 Serum enzyme activities in Case 1. GOT, Glutamate-oxaloacetate transaminase;
GPT, glutamate-pyruvate transaminase; LAP, leucine aminopeptidase; and ICDH, TPN-
dependent isocitrate dehydrogenase.
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The changes in serum enzyme activities are presented in Fig. 5.
Alkaline phosphatase levels remained normal during the strict gluconeo-
genic dietary therapy, whereas the activities of LAP, GOT, and ICDH
increased gradually above normal even with the gluconeogenic diet and
markedly rose by allowing more carbohydrate ingestions, particularly
when the general conditions of the patient became worse before death.
The GPT activity changed similarly within the normal range.
Postmortem examinations revealed a main pathological diagnosis of
primary hepatoma and its metastases to the lungs, myocardium, peritoneal
lymph nodes, adrenal grands, and descending colon. Multiple stomach
ulcers and esophageal varices were also detected. The hepatic tumor tissue
occupied most of the right lobe. The remaining intact liver in the left
lobe was hypertrophic. The tumor was histologically hepatocellular carci.
noma.
Case 2. T. M. was a 70.year.old male admitted with the diagnosis of
primary hepatoma with cirrhosis of the liver. He had complained of a
lassitude and a slight loss of appetite over six months. A weight loss of 10
kg was noted during this period. At the time of admission the weight was
65 kg and the height was 166 em. The anemia, jaundice, enlarged liver
or palpable tumor, and ascites were not present. Repeated fecal examina-
Fig. 6 A coeliaco6ram of Case 2.
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tions gave pOSItive occult blood, but X-ray examination of the upper
gastrointestinal tract failed to disclose esophageal valices, gastric ulcer or
cancer. The chest roentogenogram showed a slight elevation of the right
diaphragm, suggesting the presence of a hepatic tumor. The diagnosis
of primary hepatoma with cirrhosis of the liver was established by liver
scintiscanning and coeliacography (Fig. 6). A large defect suggestive of
the tumor occupied nearly half of the lateral upper part of the right liver
lobe. Liver function tests gave results indicative of an advanced cirrhosis
of the liver. Based on these findings, conservative treatments rather than
a radical operation were chosen.
After placing the patient on gluconeogenic diets, a loss in body
weight of 2 kg was observed in the first one month. The body weight was
restored to the original in next one month and increased 2 kg over the
initial weight thereafter. Parallel increases in the skinfold were also noted.
Ascites was not detected during the course of the dietary therapy. The
profile of dietary intakes is shown in Fig. 7. The carbohydrate content
could be reduced to as low as 40 g per day without appreciable loss of
g/day
300
o
200
Carbohydrate
Protein
tv --- ....r--- !I I
I I
I I
I
o
200
o
Cal/day
2000
o
Total calory
o 50 100 150 Days
Fig. 7 Dietary intakes in Case 2. 0 and _, See the legend to Fig. 2.
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appetite. Increases of dietary fat as well as intravenous infusion of Intra-
lipid were necessary to maintain the initially recorded total caloric intake.
The parenteral administration of the lipid caused a marked hyperlipemia;
the serum triglyceride content, which was initially in the normal range,
was elevated as high as 690 mg/ 100 m!. However, the lipid infusion was
continued as far as the serum turbidity had been cleared. The general
condition of the patient was considerably good until the 120th day of the
dietary treatment, when he developed anorexia and had a right hypochon-
drial pain. Total serum bilirubin level increased to 1.95 mg/IOO m!.
The gluconeogenic diet was discontinued at this time. On l27th day he
experienced a melena, which continued few days. After he recovered, he
consumed diets of 1200-1500 Cal/day including 200-250 g of carbohydrate.
The raised serum bilirubin level was not lowered by the relatively high
carbohydrate diets. From l50th day of the therapy, a tumor became
palpable below the costal margin. Serum alkaline phosphatase level also
increased markedly, and the patient died from repeated gastrointestinal
bleedings.
The scintiphotographs shown in Fig. 8 indicated a relatively small
increase of the tumor during the initial period of the gluconeogenic dietary
Fig. 8 Liver scintiphotographs in Case 2. The left, 12 days before starting the gluco-
neogenic diet and the right, 37th day of the dietary therapy.
therapy. The levels of blood metabolites and serum enzymes in the entire
course of illness are given in Figs. 9 and 10, respectively. Following the
reduction of carbohydrate and the increase of fat, the NEFA concentra-
tion varied over a wide range, probably depending on the period of time
after the intravenous infusion of the lipid. The citrate level was consis-
tently rai~ed during the period of the strict gluconeogenic diet. No marked
8
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150 Days
Blood sugars (mg/IOG ml)X 10-2, 0; Blood citrate (mM)X 10, .; ~erum NEFA
(mEq/l)X 1, ..
3,..--------------------------------..
...(4.58)
I
I
I
2
OL..----'----------'---------..I--------...I-----'o 50 100
Fig. 9 Metabolite concentrations in the fasting blood and serum in Case 2.
changes in blood sugar concentration were observed during the whole
therapeutic period. Serum alkaline phosphatase, GOT, CPT, and ICDH
levels were initially slightly high and further increased with the low carbo-
hydrate-high fat diet. These enzyme levels tended to decrease slightly
after restoring regular dietary regimen except for alkaline phosphatase,
which elevated markedly after the dietary carbohydrate content was
increased and the tumor became papable. The change in activity of LAP
was similar to that of alkaline phosphatase.
By postmortem examinations, the cause of the melena was indicated
to be due to a valix bleeding in the cardiac region of the stomach. The
tumor occupied nearly 80 per cent of the enlarged cirrhotic liver. Intra-
hepatic metastases of the tumor were also detected. The tumor was histolo-
gically well differentiated hepatocellular carcinoma and the cirrhosis was
of Type B.
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GOT (K. U.)X 10-2, .; GPT (K. U.)X 10-2, .A.; ICDH (mU/hr/ml)X 10-3, X ; Alkaline
phosphatase (B. U.)X 10-1, 0
2
50o
ol-..--+----------l.-------~------__:_:_:_::___::__--'
100 150 Days
Fig. 10 Serum enzyme activities in Case 2.
Case 3. S.O., a 51.year-old male, had complained of anorexia and
fullness in the upper abdomen for several months and noticed a swelling
in the epigastric region one month before admission. Two kg of weight
loss in two months were also noted. On admission the weight was 46 kg
and the height was 155 em. Physical examinations revealed no anemia,
jaundice, and ascites. The liver was enlarged and tumor masses were
palpable (Fig. 11). The spleen was also enlarged below the costal margin.
The diagnosis of primary hepatoma with cirrhosis of the liver was made
by liver scintiscanning (Fig. 12) and by peritoneoscopy. The latter exami·
nation disclosed a large tumor mass in the right liver lobe and its intra-
hepatic metastases.
Inspite of a reduced appetite, this patient could be placed on a gluco-
neogenic diet with minimum carbohydrate contents of less than 10 g per
day by aid of a parenteral lipid administration (Fig. 13). The loss of
weight during the period of the minimum carbohydrate diet was 2 kg;
10
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Fig, 11 Schematic representation of palpable hepatic tumors in Case 3. .", See the
legend to Fig. 1.
Fig. 12 liver scinti6rams in Case 3. The left, 11 th day and the right, 47th day.
but the net loss would be more than that in considering the gradual
accumulation of ascites and the marked decrease in skinfold. Th.e basal
metabolic rate was +57 per cent with the normal Triosorb test before
instituting the low carbohydrate diet. Measurements of the nitrogen
balance gave a mean value of - 7 g per day in the control period with a
regular diet and a value of + 1 g per day during the period of the strict
11
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Fig. 13 Dietary intakes in Case 3. 0 and _, See the legend to Fig. 2. In this patient
xylitol (25 g/day) was intravenously infused from 48th to 62nd day and recorded as carbo-
hydrate for convenience.
gluconeogenic dietary therapy. Fecal loss of lipids was not abnormally
increased during this period. By the dietary treatment, the full sensation
of the upper abdomen was transiently relieved. However, the low carbo-
hydrate-high fat diet was discontinued due to a marked hyperlipemia.
The change of diet corrected the increased levels of blood lipids, although
the general conditions were not improved, and the jaundice became
apparent. The emaciation, ascites, and jaundice were progressively in-
creased, and the patient died from the cardiac arrest.
As schematically illustrated in Fig. 11, the size of palpable hepatic
tumor increased gradually during the period of the minimum carbohydrate
therapy, although the increase was not apparent from the results of liver
scintiscanning (Fig. 12). The tumor mass below the costal margin started
increasing rapidly around 50th day of the therapy despite the fact that the
dietary carbohydrate content was kept below 10 g per day. After allowing
carbohydrate intake at libitum due to the hyperlipemia, the tumor growth
12
Acta Medica Okayama, Vol. 25 [1971], Iss. 2, Art. 6
http://escholarship.lib.okayama-u.ac.jp/amo/vol25/iss2/6
Dietary Therapy of Hepatoma 155
appeared to be accelerated, causing a deformity of the left costal margin.
The blood metabolite profiles summarized in Fig. 14 demonstrated
Blood sugars (ms/IOO ml)X5X 10-2, 0; Blood citrate (mM) X10, .; Serum
NEFA (mEq/ I) X5, .... ; Serum triglyceride (mg/ 100 ml) X 10-2, a
15~----------
10
o LL__...I-_-I...-_-..L.
30
-_....L-_-L...-_-
6
-:":0---'-:n-o)-,s---
Fis. 14 Metabolite concentrations in the fasting blood and serum in Case 3.
that citrate, NEFA, and triglyceride concentrations, which were initially
within the normal, rose to extraordinary high levels with the minimum
carbohydrate-high fat diet. On the 45th day, the values for serum choleste-
rol, blood acetoacetate, and p-hydroxybutyrate were 439 mg/ 100 ml, 920
m/-tmoles/g, and 2.15 /-tmoles/g, respectviely; the extent of the increases
of the latter two was approximately 50 fold of the normal values. U ninary
ketone bodies were slightly to moderately positive as measured by Ketostix.
These high metabolite levels returned toward the normal after increasing
carbohydrate and reducing fat contents.
The data in Fig. 15 show that the values of GOT and G PT increased
over the normal range after initiation of the gluconeogenic therapy. The
serum LAP activity, which was slightly elevated before starting the specific
dietary treatment, tended to decrease during the initial period of the
dietary therapy. The serum alkaline phosphatase activity was also de-
creased following the carbohydrate reduction, although the changes were
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GOT (K. D.)X 10-2, ... ; GPT (K, D.)X 10-2, A; Alkaline phosphatase
(B. D.) X 10-1, 0; LAP (G.R D.) X 10-2, •
o
"I \
.. "
" D.3),
I ,
I
30
Fig. 15 Serum enzyme activities in Case 3.
(4.7)~
/~>4)
I
I
I
I
within the normal range, and started to increase rapidly following the
increase in carbohydrate content in the diet.
Percutaneous necropsy performed as a postmortem examination re-
vealed hepatocellular carcinoma and cirrhosis of the liver (Type m.
Case 4. K. K., a 59-year.old male, with a history of hepatitis at the
age of 50 years was admitted with the chief complaint of epigastric pains
lasting about three months. A marked loss of body weight, 3 kg in one
month, was noted. At the time of admission the weight was 71 kg and the
height was 166 em. Slight anemia and jaundice were noticed but ascites
was not detected. The liver edge with a tumor mass was palpable 10 cm
below the xiphoid process. The results of liver function tests and other
examinations were suggestive of primary hepatoma with cirrhosis of the
liver. This diagnosis was confirmed by peritoneoscopy. The tumor was in
the left lobe of the liver.
Due to a marked loss of appetite and a strong desire for carbohydrate.
containing diets in this patient, he could not tolerate the low carbohydrate
diet. His average carbohydrate intake was 100 g per day and the total
caloric intake was also decreased (Fig. 16). After around 40th day the
palpation of the liver tumor became difficult because of a marked accumu-
14
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Fig. 16 Dietary intakes in Case 4. 0 and _, See the legend to Fig. 2. Intravenous
infusion of amino acids is recorded as parenteral administrations of protein.
GOT (K. U.)X 10-2, ...... ; GPT (K. U).X 10-2, L:J..; Alkaline phosphatase (B. U.)X 10-1, 0
2
o
Fig. 17 Serum enzyme activities in Case 4.
Days
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lation of ascites. The serum bilirubin level also increased rapidly. Sympto-
matic treatments failed to improve the general conditions, and the patient
expired as a result of the cachexia.
The serum NEFA concentration was normal but the blood sugar and
citrate levels were slightly high. These metabolite levels were not altered
significantly throughout the course of illness. Urinary acetone bodies were
also negative. These results suggested that the gluconeogenic metabolic
state was not attained in this case. Slightly increased serum GOT, GPT,
and alkaline phosphatase activities at the time of admission showed fluctu-
ation during the course of illness (Fig. 17).
Postmortem examinations revealed necrotic tumor masses occupying
most of the markedly increased liver. Histologically the tumor was hepato-
cellular carcinoma associated with Type A' cirrhosis of the liver.
Case 5. W. S., a 44-year-old male, had been treated under the
diagnoses of cirrhosis of the liver and diabetes mellitus. Because of the
presence of palpable hard nodules on the liver, malignant hepatic tumors
were suspected. On admission the weight was 60 kg and the height was
161 cm. Physical findings were normal except for the enlarged liver with
the tumors. The liver edge was palpated 9 cm below the costal margin.
g/day [S c1200 Carbohydrate0
200 Protein
0 c:=J ~
200 Fat
0 cr:-J ~
Cal/day Total calory
2000 LI ~0
0 50 100 Days
Fig. 18 Dietary inta1{es in Case 5. 0 and _, See the legend to Fig. 2.
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Laboratory data were indicative of cirrhosis of the liver. The blood citrate
level and serum ICDH and LAP activities were slightly increased. Oral
glucose tolerance test gave a normal result.
The carbohydrate content of diet was reduced to 40 g per day (Fig. 18)
before the diagnosis of cystic liver associated with cirrhosis was established.
This caused a body weight loss of 5 kg. During the period of the gluco.
neogenic diet, the concentrations of serum citrate, NEFA, and triglyceride
were markedly elevated (Fig. 19), while those of blood lactate, pyruvate,
and a-ketoglutarate were inversely reduced. The result of glucose tolerance
test was diabetic. These were indicative of a gluconeogenic metabolic
state, which was attained by the low carbohydrate diet. Serum enzyme
levels, particularly GOT, GPT, and ICDH, also increased during this
period (Fig. 20). These alterations in metabolite, glucose tolerance, enzyme
activity, and body weight all returned to normal or the initial values after
resuming the regular diet. The liver and tumor sizes did not change signi.
ficantly throughout the period of hospitalization.
Blood sugars (mg/100 ml) X 10-2, 0; Blood citrate (mM) X5, .; Serum
NEFA (mEq/I)X2, .; Serum triglyceride (mg/IOO ml)XlO-2, L:!..
3.....-------------------------,
OL..-OL--------j..l.O----------j...Lll-U-----.:-]J-i1,,-,.;---'
Fi5. 19 Metabolite cO:1centrations in the fastin.s blood and serum in Case 5.
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GOT (K. U)X1O-2, ... ; GPT (K. U.)XIO-2, A; ICDH (mU/hr/ml)X2X1O-3,
X; Alkaline phosphatase (B, U) X 10-1, 0; LAP (G-R U) X2 X 10-3, •
0""---'---------'---------'---------'a 50 100 Days
Fig. 20 Serum enzyme activities in Case 5.
Activities of relatively stable enzymes, hexokinase, glucose 6. phos.
phate dehydrogenase, and fructose 1,6.diphosphatase, were measured on
necropsied tumor and non-tumor liver tissues (Table n Higher activities
TABLE I. ENZYME ACTIVITIES IN LIVER AND TUMOR TISSUES
HK
Non-tumor liver
G6PDH FDPase HK
Tumor tissue
G6PDH FDPase
Normal control 2.9 21.5 95.8
(Mean ± S. D.) ±0.2 ± 3.6 ±15.8
Case 1 0.9 28.2 118 5.7 8.9 0
Case 2 17.8 51.6 85 24.5 77.8 18.9
Case 4 38.6 138 250.0 10.4
HK, hexokinase; G6PDH, glucose 6-phosphate dehydrogenase; FDPase, fructose 1,6-
diphosphatase. Enzyme activities are expressed as m.umoles/min/mg protein.
of hexokinase and glucose 6. phosphate dehydrogenase were found with the
tumor and non· tumor tissues of cirrhotic patients. The activity of fructose
1, 6-diphosphatase was absent or very small in all the hepatoma tissues.
18
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The effects of gluconeogenic diets on three cases of primary hepatoma
in the present study were essentially identical to those observed in our
previous study on the patient with hepatic metastases of malignant mela-
noma (1); namely, I) a transient inhibition or marked retardation of the
tumor growth, 2) decreases or slower increases in alkaline phosphatase
and LAP activities in serum, and 3) subjective improvements and a fairly
good clinical course of the illness. These results were derived from com·
paring the above parameters during the gluconeogenic period with those
after returning to the regular diet and also with those of the control patio
ents treated with regular diets.
In Case 1, who had primary hepatoma without complication of cirrho-
sis of the liver, a small but definite decrease in the tumor size in the early
stage of the low carbohydrate diet was observed and the serum enzyme
activities were maintained at relatively low levels. In Cases 2 and 3, who
had cirrhosis of the liver in addition to the hepatoma, the growth of the
tumor was only partially inhibited, whereas serum alkaline phosphatase or
LAP activity was even decreased temporarily. Those effects were neither
apparent in the hepatoma Case 4, whose metabolic patterns were not
gluconeogenic, nor in the control without malignant tumor, Case 5, who
had definitely enhanced gluconeogenic patterns of metabolism. Inciden-
tally, marked rises in serum GOT, GPT, and ICDH activities were found
only in patients having cirrhosis of the liver; thus these parameters can
not be regarded as an exact measure of tumor growth when underlying
cirrhosis is present. Hyperlipemia developed also in cirrhotic patients
under conditions with high fat diets, indicating a difficulty of treating
tumor patients having cirrhosis of the liver with gluconeogenic diets.
It is of some interest that the decrease in tumor size was found with
the hepatoma lacking fructm:e 1, 6.diphosphatase activity (Case 1) and that
the tumor growth could not be completely inhibited with the well differ-
entiated hepatoma, which retained considerable fructose 1, 6.diphosphatase
activity (Case 2), iI1 view of the fact that the growth. inhibiting effect of
the gluconeogenic diet was originally observed with the Novikoff hepa-
toma, which had no detectable fructose 1, 6-diphosphatase activity (5).
The increased level of blood citrate, which was considered as related
to the inhibitory effect of the gluconeogenic diet on the tumor growth (l),
appeared to have no relevance to the presently observed inhibition or
retardation of tumor growth. Since the gluconeogenic diet has a higher
value of specific dynamic action compared with the balanced diet, the
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isocaloric, low carbohydrate diet may partially inhibit the tumor growth
by decreasing energy supply (6). This effect would be accentuated by the
increased requirement of calory in the tumor-bearing host as may be seen
in Case 3, who revealed an increase in the basal metabolic rate with
normal thyroid function. However, it could be also stated that the admi·
nistration of the isocaloric, gluconeogenic diet is still better than not to
give it and to cause a severe or near total starvation in a sense that the
former prevents the patient from cachexia by supplying additional calories
and body constituents (7).
Since the clinical course of human hepatoma varies widely with indivi·
dual cases) general conclusions as to the effect of the gluconeogenic diet
on the survival time must wait further studies.
SUMMARY
Three inoperable patients with primary hepatoma could be placed on
gluconeogenic diets (minimum carbohydrate-high fat diets) for one to
three months. A transient inhibition or a marked retardation of the tumor
growth was observed with these patients and their entire clinical courses
were fairly good. These results confirmed our previous observation with a
metastatic liver tumor patient.
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